CPMD — CANNAPHARMARX, INC.

—
OTC · Health Care · Pharmaceuticals · CIK 1081938 · Alberta, Canada
Last close
$0.00
Market Cap
$1.42M
52W High
$0.01
52W Low
$0.00
ADV30
52,331
Next earnings
—

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Jun 2026 276,218 -138,446 -378,831 -1,909,042 6,891,942 555 37,722,503
Mar 2026 627,462 -409,453 -682,343 -382,021 6,580,734 633 36,850,622
Dec 2025 138,630 -521,091 -893,553 -7,549,585 7,018,404 1,804 37,172,133
Sep 2025 656,606 -440,000 -935,646 -1,477,811 11,616,907 927 34,133,650

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-431,377
Investing CF
$0
Financing CF
$436,321
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$0.00
As of
2026-08-23

Balance + Analyst (yfinance extras)

Retained Earnings
$-112,697,611
Inventory
$902,913
Receivables
$26,008
ST Investments
—
EBIT TTM
$-8,201,817
Pretax Income TTM
$-10,822,875
Interest Exp TTM
$2,621,058
Analysts
—

Yahoo Snapshot (yfinance, live)

Total Revenue
$1,698,916
EBITDA
—
Free Cash Flow
$-2,696,732
Enterprise Value
$22,679,738
Total Cash
$555
Total Debt
$20,633,496
Shares Out
708,689,905
Trailing EPS
$-0.02
Book Value
$-0.04
ROE
—
ROA
-18.7%
Div Yield
—

Annual Trend (SEC EDGAR, last 5y)

Revenues vs Net Income (last 5y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 1,362,163 -3,347,764 -11,131,448 7,020,000 37,200,000 -30,153,729 -789,102
Dec 2024 820,137 -3,630,949 -9,905,789 10,800,000 30,645,334 -19,809,637 -1,697,232
Dec 2023 0 -1,581,104 3,688,456 11,700,000 23,898,863 -12,153,213 -2,274,452
Dec 2022 0 -5,211,809 -8,531,020 6,340,000 23,681,550 -17,344,456 -1,448,363
Dec 2021 — — — — — — —

Peers — same industry

TickerNameMarket CapLastDaily %
PTIX Protagenic Therapeutics, Inc.\new $1.40M $0.77 —
PPCB Propanc Biopharma, Inc. $1.44M $0.63 —
LIFD LFTD PARTNERS INC. $1.48M $0.10 —
GCAN TRAFALGAR INTERNATIONAL, INC. $1.60M $1.61 —
ATXI AVENUE THERAPEUTICS, INC. $1.65M $0.50 —

News headlines (Yahoo Finance, 1h cache)

CannaPharmaRX Provides Corporate Update and Outlines Growth Strategy for 2026
2026-01-13 00:00 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.